One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Association between Noninvasive Liver Biomarkers and Graft Outcomes in Kidney Transplantation Recipients.
doi : 10.1159/000542914
Volume 56(3) pgs. 247-390 June 2025
Sex Differences in the Risk of Bladder Cancer among Kidney Transplant Recipients and Patients with Kidney Failure Receiving Hemodialysis: A Nationwide Cohort Study.
doi : 10.1159/000543298
The Superiority of European Kidney Function Consortium Cystatin C-Based Formula for Risk Stratification of All-Cause and Cardiovascular Deaths in US Adults.
doi : 10.1159/000542912
Minimal Change Disease and Focal Segmental Glomerulosclerosis Are Associated with Good Kidney Prognosis and Thrombotic Microangiopathy with Poor Kidney Survival in Patients with COVID-19-Associated Nephropathies.
doi : 10.1159/000542836
Plasma Transcriptome Profile Associated with Chronic Kidney Disease Progression.
doi : 10.1159/000542707
Assessing Predictors of Acute and Chronic Thrombotic Microangiopathy in Native and Allograft Biopsies.
doi : 10.1159/000542025
Association between Serum Iron Store Biomarkers and All-Cause Mortality in Japanese Patients Undergoing Hemodialysis: A Nationwide Cohort Study.
doi : 10.1159/000543888
Performance of New Race-Free eGFR Equations for Predicting Complications in Chronic Kidney Disease: From the KNOW-CKD Study.
doi : 10.1159/000543324
A New Model of Chronic Kidney Disease, Metabolic Derangements, and Heart Failure with Preserved Ejection Fraction in Aging Swine.
doi : 10.1159/000543327
Effects of Roxadustat on Thyroid Profiles in Patients and Animals with Chronic Kidney Disease.
doi : 10.1159/000542699
Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney Disease Registry Study.
doi : 10.1159/000543201
A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study).
doi : 10.1159/000543280
